83 results
Page 3 of 5
PRE 14A
dhbx3 k4d5
15 Mar 21
Preliminary proxy
9:00am
424B5
6o0npgmu9y6ks3
26 Feb 21
Prospectus supplement for primary offering
5:30pm
8-K
EX-99.1
hzec4wdhsqntev
26 Feb 21
Recro Reports Fourth Quarter and Year End 2020 Financial Results
7:05am
424B5
fz8uimli
10 Aug 20
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
mcvofg
10 Aug 20
Recro Reports Second Quarter 2020 Financial Results
7:06am
8-K
EX-2.1
nn88rl d9tk7i5y
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-10.1
xj6syemp 6n13q
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-10.1
lkus9gq55
4 Mar 19
Entry into a Material Definitive Agreement
7:05am
424B5
a4zbhinur
19 Feb 19
Prospectus supplement for primary offering
8:39am